Study looks at type 2 diabetes drug that could help those with type 1 diabetes

A new study into the common type 2 diabetes drug sitaglipti, which is sold as Januvia, is investigating whether it could reduce levels of blood sugar in patients suffering from type 1 diabetes .
With a recent study indicating that the drug could have similar effects in those with type 1 diabetes as it does for those with the type 2 version of the metabolic condition, it is hoped that successful piloting could lead to it being a effective alternative for those wanting to improve the management of their type 1 diabetes.
The new trial, by Satish Garg of the University of Colorado, showed that Januvia, a DPP-4 inhibitor taken once a day, helped to reduce blood sugar levels and HbA1C, as well as lowering the amount of insulin needed by the patients. DPP-4 inhibitors are a type of drug that is normally used by people with type 2 diabetes.
The researchers now plan a follow-up four-month trial involving 120 people with type 1 diabetes to see if Januvia can improve overall glucose control, and potentially reduce post-meal glucose levels . People with type 1 diabetes often experience increases in post-meal glucose levels, which lead to a greater need for insulin.
However, there are still concerns that there may be a danger for people with type 1 diabetes using such a drug intended for those with type 2 diabetes, as the risks have not yet been fully determined.